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Abstract
Background: In most resource-poor settings, malaria is usually diagnosed based on clinical signs
and symptoms and not by detection of parasites in the blood using microscopy or rapid diagnostic
tests (RDT). In population-based malaria surveys, accurate diagnosis is important: microscopy
provides the gold standard, whilst RDTs allow immediate findings and treatment. The concordance
between RDTs and microscopy in low or unstable transmission areas has not been evaluated.
Objectives: This study aimed to estimate the prevalence of malaria parasites in randomly selected
malarious areas of Amhara, Oromia, and Southern Nations, Nationalities and Peoples' (SNNP)
regions of Ethiopia, using microscopy and RDT, and to investigate the agreement between
microscopy and RDT under field conditions.
Methods: A population-based survey was conducted in 224 randomly selected clusters of 25
households each in Amhara, Oromia and SNNP regions, between December 2006 and February
2007. Fingerpick blood samples from all persons living in even-numbered households were tested
using two methods: light microscopy of Giemsa-stained blood slides; and RDT (ParaScreen device
for Pan/Pf).
Results: A total of 13,960 people were eligible for malaria parasite testing of whom 11,504 (82%)
were included in the analysis. Overall slide positivity rate was 4.1% (95% confidence interval [CI]
3.4–5.0%) while ParaScreen RDT was positive in 3.3% (95% CI 2.6–4.1%) of those tested.
Considering microscopy as the gold standard, ParaScreen RDT exhibited high specificity (98.5%;
95% CI 98.3–98.7) and moderate sensitivity (47.5%; 95% CI 42.8–52.2) with a positive predictive
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under field conditions.
Conclusion: Blood slide microscopy remains the preferred option for population-based
prevalence surveys of malaria parasitaemia. The level of agreement between microscopy and RDT
warrants further investigation in different transmission settings and in the clinical situation.
Background
Malaria is one of the leading public health problems in
Ethiopia. About 75% of the total area of the country is
malarious, with more than two thirds of the total popula-
tion estimated to be at risk of infection [1,2]. Malaria
transmission in Ethiopia is seasonal, depending mostly
on altitude and rainfall. The two main seasons for trans-
mission of malaria in Ethiopia are September to Novem-
ber, sometimes extended to December after heavy
summer rains, and March to May, after the light rains [3-
5]. Malaria epidemics are relatively frequent [6,7] involv-
ing highland or highland fringe areas, mainly areas
1,000–2,000 meters above sea level, in which the popula-
tion lacks immunity to malaria [3,8,9]. In Ethiopia, Plas-
modium falciparum and Plasmodium vivax account for
about 60% and 40% of infections, respectively, during the
peak transmission period [3,10].
Early diagnosis and prompt treatment is one of the key
strategies for malaria control. Clinical diagnosis is widely
used in areas where laboratory facilities are not available;
however, it is unreliable due to the non-specific nature of
signs and symptoms of malaria [10,11]. Microscopy still
remains the gold standard for laboratory diagnosis of
malaria, although it is not accessible and affordable in
most peripheral health facilities. Recent advent of rapid
diagnostic tests (RDT) for malaria may be a significant
step forward in case detection, management and reduc-
tion of unnecessary treatment. Such RDT could also be
useful in malaria diagnosis during population-based sur-
veys and to provide immediate treatment based on the
results. However, the accuracy of RDT under field condi-
tions in low transmission areas remains questionable
[11].
There are numerous malaria rapid diagnostic tests that are
commercially available [12], all of which detect malaria
antigen in blood flowing along a membrane containing
specific anti-malaria antibodies. The tests fall into a few
basic types depending on which antigen is targeted. Most
tests which detect P. falciparum are based on the histidine-
rich protein 2 (HRP-2), which is specific to that species.
Other tests detect the parasite enzyme lactate dehydroge-
nase (LDH), using either monoclonal antibodies which
react with LDH of all species including P. falciparum (so-
called PAN or pLDH), or antibodies specific for P. falci-
parum LDH. Other antigens including aldolase (which can
distinguish non-P. falciparum from mixed infections) and
other P. vivax specific tests are in early development or
use. A distinction between the HRP-2 and LDH based tests
is that HRP-2 may persist in the blood stream for days or
weeks after treatment, whereas LDH is only detected if live
parasites are present.
In addition to variation in antigen detected, the tests are
available in many formats including plastic cassettes,
cards or dipsticks, and quality depends on manufacturer
as well as storage conditions. Recent reviews from clinical
trials have found that HRP-2 based P. falciparum-specific
tests generally have greater sensitivity (over 90%) than the
pLDH-based tests when compared with microscopy in
clinical cases, whilst sensitivity of pLDH tests for non-P.
falciparum species was low [13-15]. Specificity of both
types of tests was reported to be good (>85%). Despite the
encouraging results from the RDT trials in clinical cases,
there is limited information about their accuracy and pre-
dictive value in population based surveys of malaria prev-
alence, where people may not have clinical signs and
parasitaemia is likely to be lower than in a clinic setting.
In field conditions, RDTs may be exposed to leads of heat
and humidity greater than those recommended by the
manufacturer.
The Carter Center is one of the partners in malaria control
in Ethiopia and is committed to integrated malaria con-
trol with trachoma (Amhara region) and onchocerciasis
(Oromia and SNNP regions). The Carter Center contrib-
uted three million long-lasting insecticidal nets (LLIN) in
2007 to the total 20 million distributed nationally in the
last three years [16]. The purpose of this study was to col-
lect baseline information on the prevalence of malaria
parasites at a community level in three regions of Ethio-
pia, prior to mass distribution of LLINs. The gold standard
for determining parasite prevalence was thick and thin
blood films, stained with Giemsa and examined at 1,000×
magnification. In the field ParaScreen RDT, which detects
both P. falciparum using HRP-2 and all species (PAN)
using pLDH, was used so that immediate treatment could
be offered for those with positive tests. This design ena-
bled evaluation of the agreement between ParaScreen
RDT and microscopy diagnoses of malaria under field
conditions.Page 2 of 7
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Study settings and study population
This is a population based cross-sectional survey that was
conducted in three regions of Ethiopia (Amhara, Oromia
and SNNP) between mid-December, 2006 and mid-Feb-
ruary, 2007. The sample size estimation and sample selec-
tion process have been described elsewhere [16]. Briefly, a
multistage cluster random sampling design was used to
select 224 clusters, and 25 households were randomly
selected in each cluster. Clusters were defined as kebeles
(the smallest administrative unit with an average popula-
tion of 5,000). All consenting residents (all age groups
and both sexes) of even- numbered households had their
blood tested for malaria parasites.
Malaria parasite detection
In the field, blood samples collected from the study par-
ticipants were tested for malaria parasites using ParaS-
creen RDT (Zephyr Biomedical Systems, Verna, Goa,
India). ParaScreen is an immunochromatographic test
that detects the presence of pan malaria specific antigen
(pLDH) for the detection of all non-falciparum malarial
parasites whereas the detection of P. falciparum utilises
recognition of specific histidine rich protein-2 (HRP-2).
The test uses approximately 5 μl of blood and is readable
after 15 minutes following the manufacturer's instruc-
tions. Participants with positive RDT results were offered
immediate treatment according to national guidelines:
CoArtem® for P. falciparum infection; chloroquine for
other Plasmodium infection; and clinic-based quinine ther-
apy for pregnant women [10].
In addition, two blood slides, each composed of thick and
thin films, were prepared for each participant by a medical
laboratory technician according to standard WHO-
approved protocol [17]. Slides were labelled and air-dried
horizontally in a slide tray in the field. Thin films were
fixed immediately after drying with methanol. Slides were
stained with 3% Giemsa at the nearest health facility at the
end of the day. Usually, field teams returned to the clinic
each evening but when working in inaccessible areas,
which required walking up to eight hours each way, they
were obliged to sleep in the field and stain the slides the
following day. To ensure maximum participation, house-
holds with absentees were revisited up to two times on the
same day.
Blood slides were read at a reference laboratory in Addis
Ababa and classified qualitatively as either negative, P. fal-
ciparum-positive, P. vivax-positive, or mixed infection.
One hundred high power fields of the thick film were
examined at a magnification of 1,000×, before identifying
a slide as negative or positive. If positive, the thin film was
read to determine the species. Parasite density was not
quantified. To ensure accuracy, all positive slides and a
random sample (5%) of the negative slides were re-exam-
ined by a separate expert microscopist, who was blinded
to the diagnosis of the first slide-reader. The level of agree-
ment between first and second readings was 99.4%. The
second slide from each participant was read if the first was
broken or unreadable. The identity of survey participants
who had positive blood slides was sent back to the field
teams for follow-up and appropriate treatment, where
necessary.
Statistical analysis
Statistical analysis was conducted using Stata 8.2 (Stata
Corporation, College Station, Texas). Distribution of par-
ticipants' characteristics and malaria parasite prevalence
were assessed using contingency tables while differences
in proportions were compared using the chi square test.
Taking blood slide microscopy as the gold standard, the
performance of the rapid diagnostic test was compared to
generate summary statistics for diagnostic tests using the
diagt module in Stata [18].
Ethical consideration
The protocol received ethical approval from the Emory
University Institutional Review Board (IRB 1816) and the
Amhara, Oromia and SNNP Regional Health Bureaus.
Signed informed consent was sought from each individ-
ual and parents of children aged under 18 years and
signed assent was sought from children older than 10
years in accordance with the tenets of the declaration of
Helsinki for blood films. Personal identifiers were
removed from the data set before analyses were under-
taken.
Results
The demographic characteristics of the study participants
are shown in Table 1. A total of 13,960 people in 2,692
households were enumerated of whom 2,456 (18%) were
excluded from analysis due to missing data (Figure 1). Of
the 11,504 people included in the analysis, 53.8% were
female and the overall mean age was 20.7 years.
The malaria parasite prevalence by blood slide micros-
copy and ParaScreen RDT are shown in Table 2. The prev-
alence by blood slide microscopy overall was 4.1% (95%
CI 3.4 – 5.0%) and by Para Screen RDT it was 3.3% (95%
CI 2.6–4.1%). By region, the prevalence by blood slide
was 4.6% (95% CI 3.8–5.6) in Amhara, 0.9% (95% CI
0.5–1.6) in Oromia, and 6.1% (95% CI 4.5–8.5) in
SNNP. The prevalence of malaria parasites by blood slide
microscopy was higher than prevalence by ParaScreen
RDT in Amhara (P = 0.001) and lower than RDT in Oro-
mia (P < 0.001). There was no statistically significant dif-
ference between the two diagnostic methods in SNNP (P
= 0.3).Page 3 of 7
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negative predictive value of ParaScreen RDT against blood
slide microscopy for all species of malaria combined are
shown in Table 3. The overall sensitivity was 47.5% (95%
CI 42.8–52.2) and ranged from 41.0% in SNNP to 50.0%
in Oromia. Specificity of ParaScreen RDT was 98.5% over-
all and ranged from 95.7% in SNNP to 99.4% in Amhara.
The overall positive predictive value was 56.8% (95%CI
51.7–61.9) and ranged from 36.1% to 77.8% depending
on region, while negative predictive value was very high
(97.9%).
The sensitivity and specificity of ParaScreen RDT com-
pared to blood slide microscopy for the different malaria
species are shown in Table 4. Because both the Pf-specific
and the 'PAN' antigen used by the ParaScreen RDT are
detected in P. falciparum infections, giving the result "Pf
plus PAN" even for non-mixed P. falciparum infections, it
was not possible to directly compare the performance of
the test against P. falciparum single infections detected by
slide. Therefore, the sensitivity and specificity of "Pf or
mixed" (by slide) to "Pf plus PAN" (by RDT) were com-
pared; whilst non-P. falciparum infections detected by
slide were compared directly to the "PAN only" RDT
results.
The sensitivity of the ParaScreen RDT for P. falciparum or
mixed infection compared to slide microscopy was 51.4%
(95% CI 45.5–57.5) (Table 4). Much lower sensitivity of
30.7% (95% CI 24.1–38.0) was found for non-P. falci-
parum species. However, specificity was very high for both
species: 99.0% (95% CI 98.8–99.) for P. falciparum or
mixed and 99.4% (95% CI 99.2–99.5) for non-P. falci-
parum malaria.
Discussion
This large population based survey was conducted during
the late transmission season during a non-epidemic year
for malaria in Ethiopia. The study used the conventionally
accepted standard malaria diagnostic method, light
microscopy of peripheral blood slides, and a new tech-
nique (ParaScreen rapid diagnostic test, RDT). Overall,
more infections were detected by blood slide microscopy
(4.1%) than by ParaScreen RDT (3.3%), although the dif-
ference was not statistically significant. However, by
region, significantly more infections were detected by
RDT in Oromia and significantly fewer by RDT in
Amhara.
Despite little difference between the overall prevalence of
malaria detected by the two tests, the overall sensitivity of
Table 1: Demographic characteristics of the study participants in 
three regions
Region Male n (%) Female n (%) Total N Age mean (SD)
Amhara 3,495 (45.6) 4,169 (54.4) 7,664 20.7 (17.7)
Oromia 921 (46.5) 1,061 (53.5) 1,982 18.1 (16.9)
SNNP 897 (48.3) 961 (51.7) 1,858 19.5 (16.1)
Total 5,313 (46.2) 6,191 (53.8) 11,504 20.7 (17.7)
SD, standard deviation
The sample populationFigure 1
The sample population.
13,960 people in 2,692 even numbered
households eligible for malaria screening
People excluded from analysis
•1,748 not tested
•610 tested but missing results
•98 missing age or sex
11,504 (82%) included in analysisPage 4 of 7
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cates that there was substantial non-overlap between the
positives detected by each test. The positive predictive
value was correspondingly low (56.8%). Surprisingly,
SNNP region had a positive predictive value of only
36.1% (95% CI 27.5–45.4) which was lower than
expected given that SNNP had the highest prevalence of
malaria parasites based on microscopy as the gold stand-
ard.
Reports from elsewhere indicated that RDTs have shown
a comparable level of accuracy to microscopy in clinical
settings [19,20]. The sensitivity of the RDTs observed in
our study is much lower than predicted by previous stud-
ies [13-15]. This difference may arise for two reasons:
firstly, it is possible that parasitaemias were very low in
people not seeking treatment; and secondly, the RDTs
were possibly defective or handled inappropriately caus-
ing them to lose sensitivity. Light microscopy can rou-
tinely detect parasitaemia levels as low as 40 parasites/μl,
and experienced microscopists can detect as low as 5–10
parasites/μl of blood [11], whereas RDTs usually have a
capacity to detect 100 parasites/μl of blood [11,19]. The
lack of sensitivity of RDTs at low parasitaemia compared
to microscopy is one of the shortcomings noted elsewhere
[11,19,20], which is possibly also reflected in our find-
ings. Regarding the quality of RDTs, the diagnostic accu-
racy can be affected by several factors such as quality of the
products, storage temperature and humidity, and end
users' performance [11,21]. The RDTs used in this study
were manufactured in May and June 2006 with an expiry
date of April 2008 suggesting that they should have been
in a good condition during the survey field work (mid-
December 2006 to mid February, 2007). However, the
results suggest that an appropriate quality control scheme
should accompany any effort to initiate the use of RDT at
a population based scale, especially in remote settings.
In general, the prevalence of malaria showed significant
variation among the regions surveyed, but the overall
prevalence was low. As would be expected, two malaria
parasite species, P. falciparum and P. vivax were identified
by microscopy in this study. In Ethiopia, the two predom-
inant malaria species recorded are P. falciparum (~60%)
and P. vivax (~40%) [3,22,23]. However, this proportion
can change during hot-dry seasons following the peak
transmission period, when more relapse cases could be
expected due to P. vivax infection, [24]. The preponder-
ance of one malaria species over the other at a particular
period might vary from one area to another, not only
depending on climatic and seasonal factors but also
owing to variation in geographical localities [25].
Even though clinical history of the participants was not
recorded in our study, evidence from other studies
showed that RDT positive cases missed by microscopy
might be individuals who had been treated but in whom
antigenemia persists [20,21]. ParaScreen RDT exhibited
more sensitivity to P. falciparum or mixed infections than
to non-P. falciparum (most likely P. vivax) infection. In
addition to intrinsic lower sensitivity of the antigen used,
this might be attributed to the longer persistence of P. fal-
Table 2: Malaria prevalence by region based on blood slide microscopy and Rapid Diagnostic Test (ParaScreen)
Region Number tested Blood slide microscopy Rapid diagnostic test (ParaScreen)
Pf % Pv % Pf & Pv % Total % (95%CI) Pan/Pf % Pan % Total % (95%CI)
Amhara 7,664 2.4 1.9 0.4 4.6 (3.8–5.7) 2.0 1.1 3.1 (2.4–3.9)
Oromia 1,982 0.7 0.1 0 0.9 (0.5–1.6) 1.5 1.2 2.6 (1.1–6.5)
SNNP 1,858 3.6 1.8 0 5.4 (3.4–8.5) 4.5 1.7 6.2 (3.6–10.2)
Total 11,504 2.2 1.6 0.3 4.1 (3.4–5.0) 2.1 1.1 3.3 (2.6–4.1)
Pf, Plasmodium falciparum; Pv, Plasmodium vivax
Table 3: Sensitivity, specificity, positive predictive value and negative predictive value of blood slide microscopy compared to Rapid 
Diagnostic Test (ParaScreen)
Region Sensitivity Specificity Positive predictive value Negative predictive value
% 95%CI % 95%CI % 95%CI % 95%CI
Amhara 49.4 (43.9–54.9) 99.4 (99.1–99.5) 77.8 (71.6–83.0) 97.7 (97.4–98.1)
Oromia 50.0 (24.7–75.3) 97.9 (97.2–98.5) 16.3 (7.3–29.7) 99.6 (99.2–99.8)
SNNP 41.0 (31.5–51.0) 95.7 (94.6–96.6) 36.1 (27.5–45.4) 96.4 (95.5–97.3)
Total 47.5 (42.8–52.2) 98.5 (98.3–98.7) 56.8 (51.7–61.9) 97.9 (97.6–98.1)Page 5 of 7
(page number not for citation purposes)
Malaria Journal 2008, 7:118 http://www.malariajournal.com/content/7/1/118ciparum antigen (HRP-2) after treatment or resolution
than pLDH antigen [21,26]. Other studies have also dem-
onstrated that the HRP-2 assay showed more sensitivity
compared to the pLDH antigen based assay due to quick
clearance of the latter antigen after treatment [27].
In this study, quantitative parasite counts were not con-
ducted; nonetheless, there were cases with high loads of
malaria parasites with asexual stages (ranging ++ to ++++
per high power field) which turned out to be negative by
RDT. This phenomenon suggests the possibility of under
diagnosis of malaria parasites by RDT [19] and requires
further investigations in the Ethiopian context. A similar
observation was reported from other settings where RDT
showed false negative results in the presence of high par-
asitaemia [25] implying the need for a continuous quality
assurance system to be instituted at every step before dis-
seminating the RDT products to the end users.
Conclusion
Based on the results of this study, well-conducted blood
slide microscopy for malaria diagnosis for population-
based surveys remains the preferred option. The level of
the agreement between RDT and light microscopy for
malaria diagnosis warrants further investigations in clini-
cal facilities in the Ethiopian context.
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